Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seong Hee Choi

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Molecular Biology of the Cell|January 17, 2019
Tristetraprolin-mediated hexokinase 2 expression regulation contributes to glycolysis in cancer cellsDong Jun Kim, Mai-Tram Vo, Seong Hee Choi, et al.
Biochemical and Biophysical Research Communications|November 1, 2019
Tristetraprolin posttranscriptionally downregulates PFKFB3 in cancer cellsJi Hun Jang, Dong Jun Kim, Soo-Youn Ham, et al.
Cell Death Discovery|May 27, 2024
DRG2 is required for surface localization of PD-L1 and the efficacy of anti-PD-1 therapySeong Hee Choi, Muralidharan Mani, Jeonghwan Kim, et al.
The FEBS Journal|November 7, 2019
DRG2 supports the growth of primary tumors and metastases of melanoma by enhancing VEGF-A expressionNal Ae Yoon, Se Jin Jung, Seong Hee Choi, et al.
Annals of Rehabilitation Medicine|July 28, 2023
Clinical Practice Guidelines for Oropharyngeal DysphagiaSeoyon Yang, Jin-Woo Park, Kyunghoon Min, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Molecular Biology of the Cell|January 17, 2019
Tristetraprolin-mediated hexokinase 2 expression regulation contributes to glycolysis in cancer cellsDong Jun Kim, Mai-Tram Vo, Seong Hee Choi, et al.
Biochemical and Biophysical Research Communications|November 1, 2019
Tristetraprolin posttranscriptionally downregulates PFKFB3 in cancer cellsJi Hun Jang, Dong Jun Kim, Soo-Youn Ham, et al.
Cell Death Discovery|May 27, 2024
DRG2 is required for surface localization of PD-L1 and the efficacy of anti-PD-1 therapySeong Hee Choi, Muralidharan Mani, Jeonghwan Kim, et al.
The FEBS Journal|November 7, 2019
DRG2 supports the growth of primary tumors and metastases of melanoma by enhancing VEGF-A expressionNal Ae Yoon, Se Jin Jung, Seong Hee Choi, et al.
Annals of Rehabilitation Medicine|July 28, 2023
Clinical Practice Guidelines for Oropharyngeal DysphagiaSeoyon Yang, Jin-Woo Park, Kyunghoon Min, et al.
Pageof 4